Liposyn III 2%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Liposyn III 2%, covering 2009-02-20 to 2009-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent [NA]